Prevalence of depressive symptoms and associated factors among patients with tuberculosis attending public health institutions in Gede’o zone, South Ethiopia
Open Access
- 13 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s12889-020-09794-z
Abstract
Depression is a common mental disorder among patients with tuberculosis and it is associated with a greater risk of suicide, multidrug-resistant tuberculosis, and poor quality of life. Evidence suggests the early identification of depression among patients with tuberculosis is important to decrease adverse outcomes. However, there are limited studies that examined the prevalence and determinants of depressive symptoms among patients with tuberculosis. This study aimed to assess the prevalence and associated factors of depressive symptoms among patients with tuberculosis attending public health institutions in Gede’o zone, South Ethiopia. An institution-based a cross-sectional study was conducted from November 1 to December 30, 2018, among a randomly selected sample of 415 patients with tuberculosis attending public health institutions in Gede’o zone, South Ethiopia. Patient Health Questionnaire (PHQ-9) was used to assess depressive symptoms. Logistic regression was used to identify the potential risk factors of depressive symptoms. The strength of the association was presented by crude odds and adjusted odds ratio with their corresponding 95% CI. Finally, the statistical significance was set at p < 0.05. The prevalence of depressive symptoms was found to be 45.5% (95% CI; 41.1–50.1%) among patients with tuberculosis; 33.3% had moderate, 9.8% had moderately severe, and 2.4% had severe depression. After adjusting for the possible confounders, being on re-treatment for tuberculosis (AOR = 2.47, 95% CI: 1.17–5.22), aged ≥45 years (AOR = 2.41, 95% CI: 1.09–5.32), having poor social support (AOR = 4.21, 95% CI: 2.10–8.47), and Tuberculosis/Human Immunodeficiency Virus (TB/HIV) co-infection) (AOR = 3.96, 95% CI 2.0, 7.84) were significantly associated with depressive symptoms among patients with TB. This study suggests that a substantial percentage of patients with TB had depressive symptoms (45.5%). TB/HIV coinfection, being on re-treatment for tuberculosis, those having poor social support, patients aged 45 and above were factors associated with depressive symptoms. Routine screening of depression among patients with TB is warranted. Moreover, patients with TB falling into the risk categories should be more carefully monitored for depression and when possible referred to mental health professionals.Funding Information
- Dilla University (--)
This publication has 29 references indexed in Scilit:
- The Prevalence and Pattern of Depression in Patients with Tuberculosis on Follow up at Jimma University Specialized Hospital and Jimma Health CenterMedicine Science | International Medical Journal, 2014
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010PLoS Medicine, 2013
- Association of Major Depressive Episode with Negative Outcomes of Tuberculosis TreatmentPLOS ONE, 2013
- Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis PatientsTuberculosis Research and Treatment, 2013
- Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South AfricaBMC Psychiatry, 2012
- Quality of life among tuberculosis (TB), TB retreatment and/or TB-HIV co-infected primary public health care patients in three districts in South AfricaHealth and Quality of Life Outcomes, 2012
- Preventing DepressionJAMA, 2012
- The prevalence of depression and associated factors in Ethiopia: findings from the National Health SurveyInternational Journal of Mental Health Systems, 2012
- Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in ZambiaBMC Psychiatry, 2011
- A Systematic Review of the Psychiatric Side-Effects of EfavirenzAIDS and Behavior, 2011